Tilray Inc.

The momentum for this stock is not very good. Tilray Inc. is not a good value stock. Tilray Inc. is not very popular among insiders. Tilray Inc. is a mediocre stock to choose.
Log in to see more information.
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis...
TLRY Fundamental Data by TradingView

News

Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company
Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company

Globe Newswire NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ( Tilray , our , we or the Company ) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has...\n more…

Breckenridge Brewery Unveils Oktoberfest Brew and Hosts 28th Annual Oktoberfest Festival: A Weekend of Live Music, Traditional German Cuisine, and Tasty Brews in Breckenridge, Colorado
Breckenridge Brewery Unveils Oktoberfest Brew and Hosts 28th Annual Oktoberfest Festival: A Weekend of Live Music, Traditional German Cuisine, and Tasty Brews in Breckenridge, Colorado

Globe Newswire LITTLETON, Colo, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. ( Tilray or the Company ) (NASDAQ: TLRY and TSX: TLRY) is proud to announce its title...\n more…

Tilray Brands, Inc. (TLRY) Flat As Market Gains: What You Should Know
Tilray Brands, Inc. (TLRY) Flat As Market Gains: What You Should Know

Zacks Investment Research Tilray Brands, Inc. (TLRY) closed the latest trading day at $1.70, indicating no change from the previous session's end. This change lagged the S&P 500's daily gain of 0.45%. Meanwhile, the Dow lost...\n more…

Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds

Benzinga Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS).\n more…

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms

Globe Newswire LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ( Tilray ) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...\n more…

Tilray Brands (NASDAQ:TLRY) Is Making Moderate Use Of Debt
Tilray Brands (NASDAQ:TLRY) Is Making Moderate Use Of Debt

Simply Wall St David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...\n more…